REG - BlackRock Group Medtronic, Inc. - Form 8.3 - Medtronic, Inc. <Origin Href="QuoteRef">MDT.N</Origin>
RNS Number : 7434WBlackRock Group11 November 2014Ap19
FORM8.3
IRISHTAKEOVERPANEL
DISCLOSUREUNDERRULE8.3OFTHEIRISHTAKEOVERPANEL ACT,1997,TAKEOVERRULES,2013
DEALINGSBYPERSONSWITHINTERESTSINRELEVANTSECURITIESREPRESENTING1%ORMORE
1. KEYINFORMATION
Nameofpersondealing(Note1)
BlackRock, Inc.
Companydealtin
Medtronic, Inc.
Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate(Note2)
USD 0.10 common shares
Dateofdealing
10 November 2014
2. INTERESTSANDSHORTPOSITIONS
(a) Interestsandshortpositions(followingdealing)intheclassofrelevantsecuritydealtin(Note3)
Long
Short
Number
(%)
Number
(%)
(1)Relevantsecurities
60,463,867 (6.15%)
31,576 (0.00%)
(2)Derivatives(otherthanoptions)
973 (0.00%)
5,527 (0.00%)
(3)Optionsandagreementstopurchase/sell
0 (0.00%)
69,400 (0.00%)
Total
60,464,840 (6.15%)
106,503 (0.01%)
(b) Interestsandshortpositionsinrelevantsecuritiesofthecompany,otherthantheclassdealtin(Note3)
Classofrelevantsecurity:
Long
Short
Number
(%)
Number
(%)
(1)Relevantsecurities
(2)Derivatives(otherthanoptions)
(3)Optionsandagreementstopurchase/sell
Total
Ap20
1. DEALINGS(Note4)
(a) Purchasesandsales
Purchase/sale
Numberofrelevantsecurities
Priceperunit(Note5)
Purchase
78,061
USD 68.1000
Purchase
1,040
USD 68.6215
Purchase
968
USD 68.6959
Purchase
13,299
USD 68.7100
Sale
954
USD 68.1000
Sale
610
USD 68.6708
Sale
38,400
USD 68.6875
Sale
15,310
USD 68.7100
Please note: there was also a Transfer In of 17,836 Shares.
(b) Derivativestransactions(otherthanoptionstransactions)
Productname,
e.g.CFD
Natureoftransaction
(Note6)
Numberofrelevantsecurities
(Note7)
Priceperunit
(Note5)
CFD
Reducing Short
1,386
USD 68.6821
(c) Optionstransactionsinrespectofexistingrelevantsecurities
(i) Writing,selling,purchasingorvarying
Productname,
e.g.calloption
Writing,selling,purchasing,varyingetc.
Numberofsecurities towhichtheoptionrelates(Note7)
Exercise price
Type,e.g.American,Europeanetc.
Expiry date
Optionmoney paid/receivedperunit(Note5)
(ii) Exercising
Productname,
e.g.calloption
Numberofsecurities
Exercisepriceper unit(Note5)
(d) Otherdealings(includingtransactionsinrespectofnewsecurities)(Note4)
Natureoftransaction
(Note8)
Details
Priceperunit
(if applicable) (Note 5)
Ap21
2. OTHERINFORMATION
Agreements,arrangementsorunderstandingsrelatingtooptionsorderivatives
Fulldetailsofanyagreement,arrangementorunderstandingbetweenthepersondisclosing andanyotherpersonrelatingtothevotingrightsofanyrelevantsecuritiesunderanyoption referredtoonthisformorrelatingtothevotingrightsorfutureacquisitionordisposalofanyrelevant
securitiestowhichanyderivativereferredtoonthisformisreferenced.Ifnone,this shouldbestated.
None
IsaSupplementalForm8attached?(Note9) YES
Dateofdisclosure
11 November 2014
Contactname
Gareth Slade
Telephonenumber
+44 20 7743 2536
IfaconnectedEFM,nameofofferee/offerorwithwhichconnected
IfaconnectedEFM,statenatureofconnection(Note10)
Ap23
SUPPLEMENTALFORM8
IRISHTAKEOVERPANEL
DISCLOSUREUNDERRULE8.1ANDRULE8.3OFTHEIRISHTAKEOVERPANELACT,1997,TAKEOVERRULES,2013
DETAILSOFOPENPOSITIONS
(ThisformshouldbeattachedtoForm8.1(a)&(b)(i),Form8.1(b)(ii)orForm8.3,asappropriate)
OPENPOSITIONS(Note1)
Productname,
e.g.calloption
Written,orpurchased
Numberofrelevant securitiestowhichtheoptionorderivativerelates
Exercise price(Note2)
Type,e.g.American,Europeanetc.
Expiry date
Call Option
Written
12,500
USD 66.00
American
14/11/2014
Call Option
Written
35,700
USD 66.50
American
14/11/2014
Call Option
Written
21,200
USD 70.00
American
05/12/2014
Notes
1. Wherethereareopenoptionpositionsoropenderivative positions(exceptforCFDs),fulldetailsshouldbegiven.Fulldetailsofanyexistingagreementstopurchaseortosellmust alsobegivenonthisform.
2. Forallpricesandothermonetaryamounts,thecurrencymust bestated.
Forfulldetailsofdisclosurerequirements,seeRule8oftheRules.Ifindoubt,consultthePanel.
This information is provided by RNSThe company news service from the London Stock ExchangeENDISEUARVRSNAAAAA
Recent news on Medtronic
See all newsRCS - Cydar Ltd - First patient treated in Medtronic collaboration
AnnouncementRCS - Cydar Ltd - Kenneth Hitchner appointed Cydar Medical Chairman
AnnouncementRCS - Cydar Ltd - Cydar Medical raises $11.5m (£9.3m) in Series A
AnnouncementREG - Baillie GiffordJapan - Net Asset Value(s) <Origin Href="QuoteRef">BGFD.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
AnnouncementREG - Goldman Sachs (EPT) Greene King PLC - Form 8.5 (EPT/RI) - Amendment <Origin Href="QuoteRef">GNK.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
Announcement